Abstract:Background: Inhibin B appears to change earlier than traditional predictors in ovarian aging. The pattern of inhibin B levels is highest in the early to midfollicular phases followed by a decrease in the late follicular phase. This implies that it is secreted by developing follicles and reflects follicular function and oocyte number.Objective: The aim of this preliminary study was to explore the possibility of using the ratio of serum inhibin B concentrations on cycle day 2 and 7 as a predictor for the outcome of in-vitro fertilization (IVF) procedures.Materials and Methods: The subjects, who underwent their IVF/ICSI treatment from April 2004 to September 2004, were enrolled in this study. Typical long protocol with GnRHa down regulation was employed and blood samples were drawn on the cycle day 2 for baseline hormone assessments and on the cycle day 7, the first visit after the ovulation stimulation.Results: The median values of day2 Inhibin B in pregnant and non-pregnant groups were 113.4 and 172 IU/ml, respectively. The ratios of D7/D2 inhibin B in the pregnant group were all higher than 1 but distributed widely in failed group.Conclusion: Seifer et al. (1997) and Hall et al. (2000) suggested a threshold valve for inhibin B (45 pg/ml and 75 pg/ml, respectively) to predict follicular development and success of pregnancy. However, this cut-off valve could not be defined in our study. Interestingly, the ratio of D7/D2, indicating the increase of inhibin B concentrations, in the pregnant women was higher than 1. In contrast, the valves were showed to be lower than 1 in non-pregnant group. This phenomenon seems consistent with the theory which inhibin B is secreted by developing follicles; i.e. if the increase of inhibin B fails, it might indicate oocyte developing system and the response of ovarian stimulation and outcome of treatment would not be satisfactory. Therefore, the ratio of D7/D2 may help in predicting the poor responder and failure of pregnancy in IVF procedure. However, the threshold valve remains to be determined because of the sample number. Background: Inhibin B appears to change earlier than traditional predictors in ovarian aging. The pattern of inhibin B levels is highest in the early to midfollicular phases followed by a decrease in the late follicular phase. This implies that it is secreted by developing follicles and reflects follicular function and oocyte number. Objective: The aim of this preliminary study was to explore the possibility of using the ratio of serum inhibin B concentrations on cycle day 2 and 7 as a predictor for the outcome of in-vitro fertilization (IVF) procedures. Materials and Methods: The subjects, who underwent their IVF/ICSI treatment from April 2004 to September 2004, were enrolled in this study. Typical long protocol with GnRHa down regulation was employed and blood samples were drawn on the cycle day 2 for baseline hormone assessments and on the cycle day 7, the first visit after the ovulation stimulation. Results: The median values of day2 Inhibin B in pregnant and non-pregnant groups were 113.4 and 172 IU/ml, respectively. The ratios of D7/D2 inhibin B in the pregnant group were all higher than 1 but distributed widely in failed group. Conclusion: Seifer et al. (1997) and Hall et al. (2000) suggested a threshold valve for inhibin B (45 pg/ml and 75 pg/ml, respectively) to predict follicular development and success of pregnancy. However, this cut-off valve could not be defined in our study. Interestingly, the ratio of D7/D2, indicating the increase of inhibin B concentrations, in the pregnant women was higher than 1. In contrast, the valves were showed to be lower than 1 in non-pregnant group. This phenomenon seems consistent with the theory which inhibin B is secreted by developing follicles; i.e. if the increase of inhibin B fails, it might indicate oocyte developing system and the response of ovarian stimulation and outcome of treatment would not be satisfactory. Therefore, the ratio of D7/D2 may help in predicting the poor responder and failure of pregnancy in IVF procedure. However, the threshold valve remains to be determined because of the sample number.

The Ratio of Day 2 and Day 7 Serum Concentrations of Inhibin B As a Predictor of the Outcome of In-Vitro Fertilization

Association Between Luteinizing Hormone Level Decrease on the Triggering Day and Pregnancy Outcome for in Vitro Fertilization/intracytoplasmic Sperm Injection Patients Following Gonadotropin-Releasing Hormone Antagonist Protocol: a Retrospective Cohort Study

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

Association between LH level decrease on the triggering day and pregnancy outcome for IVF/ICSI patients following GnRH antagonist protocol: a retrospective cohort study

Serum LH Levels on hCG Trigger Day Affect IVF Outcomes Intensified by Poor Ovarian Reserve and Advanced Age

Recurrent Ivf Failure Is Associated With Elevated Progesterone On The Day Of Hcg Administration

Comparison of Progesterone Measurement on Day Of, and Day After, HCG Administration in IVF–embryo Transfer Cycles

[Dynamic Assay of Serum Inhibin B and Estradiol Concentrations Obtained after Gonadotrophin Therapy As Predictors of Ovarian Response in Vitro Fertilization Cycle].

The relationship between serum delta inhibin B levels and ovarian response in IVF/ICSI cycles

The Predication of the Results of in Vitro Fertilization and Embryo Transfer by the Ratio of Basal FSH and LH Level

Elevated Follicular Cortisone Level is a Negative Predictor of Clinical Pregnancy in Women Undergoing Fresh Embryo Transfer

Identification of the source of inhibins at the time of conception provides a diagnostic role for them in very early pregnancy

Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles

Value of Serum and Follicular Fluid Sirtuin (SIRT)1 and SIRT2 Protein Levels in Predicting the Outcome of Assisted Reproduction

Can Inhibin B Reflect Ovarian Reserve of Healthy Reproductive Age Women Effectively?

Serum Estradiol Level and Progesterone/Estradiol Ratio Per Follicle on HCG Administration Day in Relation to Outcomes of in Vitro Fertilization and Embryo Transfer

The predictive value of the serum follicle-stimulating hormone to luteinizing hormone ratio affter putuitary down-regulation in IVF

The serum oestradiol/progesterone ratio on the day of OPU + 7, but not the day of OPU + 5, affects the rates of live birth in fresh blastocyst embryo transfer cycles

The decline in serum estradiol on the second day after oocyte retrieval affects the outcome of IVF/ICSI-ET treatment in high ovarian responders

The Serum Follicle Stimulating Hormone-to-luteinizing Hormone Ratios Can Predict Assisted Reproductive Technology Outcomes in Women Undergoing Gonadotropin Releasing Hormone Antagonist Protocol

Serum Progesterone Concentration on Day of HCG Administration and IVF Outcome